awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33649540-4E212B3E-B0C7-4253-8B42-91F5C5B8F0E0
Q33649540-4E212B3E-B0C7-4253-8B42-91F5C5B8F0E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33649540-4E212B3E-B0C7-4253-8B42-91F5C5B8F0E0
International Clinical Trials Day 2014-ancient and modern needs.
P2860
Q33649540-4E212B3E-B0C7-4253-8B42-91F5C5B8F0E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33649540-4E212B3E-B0C7-4253-8B42-91F5C5B8F0E0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8df91b015190110625c7591b346c6e8520fcea8e
P2860
Approval after phase I: ceritinib runs the three-minute mile.